Acute Kidney Injury
A baseline creatinine measurement from clinical trial enrollment may not be the best way to detect acute kidney injury.
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Patients who have acute kidney injury while hospitalized face increased risk for morbidity and mortality after discharge.
The FDA has granted a Humanitarian Device Exemption Approval Order to the Selective Cytopheretic Device Pediatric.
Patients hospitalized with COVID-19 face increased risk for long-term adverse outcomes such as major adverse kidney events.
Community-acquired acute kidney injury (CA-AKI) is AKI that develops outside of the hospital setting.
More patients in the terlipressin group had a >30% improvement in serum creatinine from baseline than in the placebo group.
Effective blood pressure control following AKI may have beneficial effects on outcomes.
Examining the effect of SGLT2 inhibitors on biomarkers of tubular injury in patients with acute heart failure.
The difference in risk between White and Black patients was driven by greater MI risk in Black versus White patients.
Perioperative administration of acetaminophen and reduced AKI after cardiac surgery.
For all outcomes, rates of health care utilization were higher in the dialysis-treated AKI survivor group than in controls.
Advertisement
Advertisement
